Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurrent/Metastatic Hepatocellular Carcinoma
Clinical trial NCT07487402 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07487402
- Sponsor
- Zhejiang University
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-30
- Primary completion
- 2028-12-15
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.